127 related articles for article (PubMed ID: 8039897)
1. Immunogenicity of the Plasmodium falciparum glutamate-rich protein expressed by vaccinia virus.
Theisen M; Cox G; Høgh B; Jepsen S; Vuust J
Infect Immun; 1994 Aug; 62(8):3270-5. PubMed ID: 8039897
[TBL] [Abstract][Full Text] [Related]
2. Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli.
Theisen M; Vuust J; Gottschau A; Jepsen S; Høgh B
Clin Diagn Lab Immunol; 1995 Jan; 2(1):30-4. PubMed ID: 7719909
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of the Plasmodium falciparum serine repeat antigen (p126) expressed by vaccinia virus.
Tine JA; Conseil V; Delplace P; De Taisne C; Camus D; Paoletti E
Infect Immun; 1993 Sep; 61(9):3933-41. PubMed ID: 8359915
[TBL] [Abstract][Full Text] [Related]
4. A Plasmodium falciparum GLURP-MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies.
Theisen M; Soe S; Brunstedt K; Follmann F; Bredmose L; Israelsen H; Madsen SM; Druilhe P
Vaccine; 2004 Mar; 22(9-10):1188-98. PubMed ID: 15003647
[TBL] [Abstract][Full Text] [Related]
5. Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines.
Miao J; Li X; Liu Z; Xue C; Bujard H; Cui L
Vaccine; 2006 Sep; 24(37-39):6187-98. PubMed ID: 16806600
[TBL] [Abstract][Full Text] [Related]
6. Addition of the MSA1 signal and anchor sequences to the malaria merozoite surface antigen 1 C-terminal region enhances immunogenicity when expressed by recombinant vaccinia virus.
Yang S; Carroll MW; Torres-Duarte AP; Moss B; Davidson EA
Vaccine; 1997; 15(12-13):1303-13. PubMed ID: 9302735
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of Plasmodium falciparum and Plasmodium vivax circumsporozoite protein repeat multiple antigen constructs (MAC).
Udhayakumar V; Saekhou A; Fang S; Jue D; Wohlhueter RM; Lal AA
Vaccine; 1998; 16(9-10):982-8. PubMed ID: 9682348
[TBL] [Abstract][Full Text] [Related]
8. Natural antibody responses to Plasmodium falciparum MSP3 and GLURP(R0) antigens are associated with low parasite densities in malaria patients living in the Central Region of Ghana.
Amoah LE; Nuvor SV; Obboh EK; Acquah FK; Asare K; Singh SK; Boampong JN; Theisen M; Williamson KC
Parasit Vectors; 2017 Aug; 10(1):395. PubMed ID: 28835262
[TBL] [Abstract][Full Text] [Related]
9. Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum circumsporozoite protein.
Walther M; Thompson FM; Dunachie S; Keating S; Todryk S; Berthoud T; Andrews L; Andersen RF; Moore A; Gilbert SC; Poulton I; Dubovsky F; Tierney E; Correa S; Huntcooke A; Butcher G; Williams J; Sinden RE; Hill AV
Infect Immun; 2006 May; 74(5):2706-16. PubMed ID: 16622207
[TBL] [Abstract][Full Text] [Related]
10. Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial.
Hermsen CC; Verhage DF; Telgt DS; Teelen K; Bousema JT; Roestenberg M; Bolad A; Berzins K; Corradin G; Leroy O; Theisen M; Sauerwein RW
Vaccine; 2007 Apr; 25(15):2930-40. PubMed ID: 16914240
[TBL] [Abstract][Full Text] [Related]
11. Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity.
Theisen M; Dodoo D; Toure-Balde A; Soe S; Corradin G; Koram KK; Kurtzhals JA; Hviid L; Theander T; Akanmori B; Ndiaye M; Druilhe P
Infect Immun; 2001 Sep; 69(9):5223-9. PubMed ID: 11500389
[TBL] [Abstract][Full Text] [Related]
12. Plasmodium falciparum: heterologous synthesis of the transmission-blocking vaccine candidate Pfs48/45 in recombinant vaccinia virus-infected cells.
Milek RL; DeVries AA; Roeffen WF; Stunnenberg H; Rottier PJ; Konings RN
Exp Parasitol; 1998 Oct; 90(2):165-74. PubMed ID: 9769246
[TBL] [Abstract][Full Text] [Related]
13. Induction of Plasmodium falciparum sporozoite-neutralizing antibodies upon vaccination with recombinant Pfs16 vaccinia virus and/or recombinant Pfs16 protein produced in yeast.
Moelans II; Cohen J; Marchand M; Molitor C; de Wilde P; van Pelt JF; Hollingdale MR; Roeffen WF; Eling WM; Atkinson CT
Mol Biochem Parasitol; 1995 Jun; 72(1-2):179-92. PubMed ID: 8538688
[TBL] [Abstract][Full Text] [Related]
14. A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees.
Schneider J; Langermans JA; Gilbert SC; Blanchard TJ; Twigg S; Naitza S; Hannan CM; Aidoo M; Crisanti A; Robson KJ; Smith GL; Hill AV; Thomas AW
Vaccine; 2001 Sep; 19(32):4595-602. PubMed ID: 11535306
[TBL] [Abstract][Full Text] [Related]
15. Assessment of a vaccinia virus vectored multi-epitope live vaccine candidate for Plasmodium falciparum.
Dong W; Li M; Bi H; Li Y; Wu J; Qu L
Int J Parasitol; 2001 Jan; 31(1):57-62. PubMed ID: 11165271
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
17. The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro.
Theisen M; Soe S; Oeuvray C; Thomas AW; Vuust J; Danielsen S; Jepsen S; Druilhe P
Infect Immun; 1998 Jan; 66(1):11-7. PubMed ID: 9423833
[TBL] [Abstract][Full Text] [Related]
18. Antibody response profiles induced by Plasmodium falciparum glutamate-rich protein in naturally exposed individuals from a Brazilian area endemic for malaria.
Pratt-Riccio LR; Lima-Junior JC; Carvalho LJ; Theisen M; Espíndola-Mendes EC; Santos F; Oliveira-Ferreira J; Goldberg AC; Daniel-Ribeiro CT; Banic DM
Am J Trop Med Hyg; 2005 Dec; 73(6):1096-103. PubMed ID: 16354819
[TBL] [Abstract][Full Text] [Related]
19. Immunization of Saimiri sciureus monkeys with a recombinant hybrid protein derived from the Plasmodium falciparum antigen glutamate-rich protein and merozoite surface protein 3 can induce partial protection with Freund and Montanide ISA720 adjuvants.
Carvalho LJ; Alves FA; Bianco C; Oliveira SG; Zanini GM; Soe S; Druilhe P; Theisen M; Muniz JA; Daniel-Ribeiro CT
Clin Diagn Lab Immunol; 2005 Feb; 12(2):242-8. PubMed ID: 15699417
[TBL] [Abstract][Full Text] [Related]
20. Overcoming inhibition of antibody responses to a malaria recombinant vaccinia virus caused by prior exposure to wild type virus.
Etlinger HM; Altenburger W
Vaccine; 1991 Jul; 9(7):470-2. PubMed ID: 1716807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
